Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rHSA in cirrhotic ascites
NCT05858853Phase 3Completed
- Sponsor
- Protogen
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human serum albumin in ascites, sponsored by Protogen. Started May 2023; status: completed.
02
Drugs
recombinant human serum albumin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT05858853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05858853.